drugset
drugset / Trial / NCT00894517

A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia

NCT00894517 ↗

Phase 1/2 Completed 61 enrolled Allergan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a 24 week study evaluating the effects of botulinum toxin Type A on semen quality in patients with signs and symptoms of Benign Prostatic Hyperplasia (BPH).

Timeline

Start
2009-08
Primary completion
2012-06
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 200 iu Other

Indications

benign prostatic hyperplasia